On slide 15, HbA1c reduction of max. 0.6%. First, this is not dose dependent and no no-effect identified. The highest dose gave the lowest effect? In the cohort of 1.0 mg.kg (best case), 0.6% reduction from average of 8.6% is still far way from the normal of 4.5% we looking for.
Slide 16: Placebo n=2? you got to be kidding me!
Slide 18: Median change in CRP. No dose dependence at all.
Those are the comments for all the data. If you have different opionion, I will be happy to hear.